CN1036794A - 一种增加细胞激动素产率的方法 - Google Patents
一种增加细胞激动素产率的方法 Download PDFInfo
- Publication number
- CN1036794A CN1036794A CN89102021.7A CN89102021A CN1036794A CN 1036794 A CN1036794 A CN 1036794A CN 89102021 A CN89102021 A CN 89102021A CN 1036794 A CN1036794 A CN 1036794A
- Authority
- CN
- China
- Prior art keywords
- cytokinin
- value
- cell
- temperature
- insulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 239000004062 cytokinin Substances 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 238000009413 insulation Methods 0.000 claims description 9
- 230000001939 inductive effect Effects 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 2
- 230000006698 induction Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 14
- 102000000412 Annexin Human genes 0.000 description 6
- 108050008874 Annexin Proteins 0.000 description 6
- 102000000588 Interleukin-2 Human genes 0.000 description 6
- 108010002350 Interleukin-2 Proteins 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 108010050904 Interferons Proteins 0.000 description 4
- 102000014150 Interferons Human genes 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 229940079322 interferon Drugs 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 206010018910 Haemolysis Diseases 0.000 description 2
- 241000711408 Murine respirovirus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 108010074605 gamma-Globulins Proteins 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000002555 ionophore Substances 0.000 description 2
- 230000000236 ionophoric effect Effects 0.000 description 2
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- QGVLYPPODPLXMB-UBTYZVCOSA-N (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)[C@@H](O)[C@@]3(O)C(C)(C)[C@H]3[C@@H]21 QGVLYPPODPLXMB-UBTYZVCOSA-N 0.000 description 1
- HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 102000018594 Tumour necrosis factor Human genes 0.000 description 1
- 108050007852 Tumour necrosis factor Proteins 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QGVLYPPODPLXMB-QXYKVGAMSA-N phorbol Natural products C[C@@H]1[C@@H](O)[C@]2(O)[C@H]([C@H]3C=C(CO)C[C@@]4(O)[C@H](C=C(C)C4=O)[C@@]13O)C2(C)C QGVLYPPODPLXMB-QXYKVGAMSA-N 0.000 description 1
- 239000002644 phorbol ester Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1049/88 | 1988-03-04 | ||
| HU881049A HU202594B (en) | 1988-03-04 | 1988-03-04 | Process for increasing yield of leucoquines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1036794A true CN1036794A (zh) | 1989-11-01 |
Family
ID=10952631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN89102021.7A Pending CN1036794A (zh) | 1988-03-04 | 1989-03-03 | 一种增加细胞激动素产率的方法 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPH0724595B2 (enrdf_load_stackoverflow) |
| CN (1) | CN1036794A (enrdf_load_stackoverflow) |
| AT (1) | AT392800B (enrdf_load_stackoverflow) |
| DE (1) | DE3907114A1 (enrdf_load_stackoverflow) |
| HU (1) | HU202594B (enrdf_load_stackoverflow) |
| IT (1) | IT1229193B (enrdf_load_stackoverflow) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2906160A1 (de) * | 1979-02-17 | 1980-09-04 | Thomae Gmbh Dr K | Verbessertes verfahren zur herstellung von humaninterferon |
| US4357422A (en) * | 1980-08-14 | 1982-11-02 | Massachusetts Institute Of Technology | Method of enhancing interferon production |
| JPS57105195A (en) * | 1980-10-24 | 1982-06-30 | Nat Res Dev | Production of interferon |
| JPS6296083A (ja) * | 1985-10-21 | 1987-05-02 | Toray Ind Inc | 動物細胞の培養方法 |
-
1988
- 1988-03-04 HU HU881049A patent/HU202594B/hu not_active IP Right Cessation
-
1989
- 1989-03-03 AT AT481/89A patent/AT392800B/de not_active IP Right Cessation
- 1989-03-03 JP JP1050209A patent/JPH0724595B2/ja not_active Expired - Lifetime
- 1989-03-03 CN CN89102021.7A patent/CN1036794A/zh active Pending
- 1989-03-03 IT IT8919632A patent/IT1229193B/it active
- 1989-03-06 DE DE3907114A patent/DE3907114A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| HUT50218A (en) | 1989-12-28 |
| JPH01281095A (ja) | 1989-11-13 |
| ATA48189A (de) | 1990-11-15 |
| IT1229193B (it) | 1991-07-25 |
| HU202594B (en) | 1991-03-28 |
| DE3907114C2 (enrdf_load_stackoverflow) | 1991-12-19 |
| IT8919632A0 (it) | 1989-03-03 |
| DE3907114A1 (de) | 1989-09-14 |
| AT392800B (de) | 1991-06-10 |
| JPH0724595B2 (ja) | 1995-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4564593A (en) | Messenger RNA, production and use thereof | |
| Stern et al. | Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. | |
| Harigaya et al. | Murine bone marrow cell line producing colony-stimulating factor. | |
| US4216203A (en) | Process for producing interferon | |
| US4675291A (en) | Human cultured cell line | |
| US4376821A (en) | Production of human IFN-gamma (immune) interferon | |
| US4036693A (en) | Treatment of cell culture microcarries | |
| US4440860A (en) | Stimulating cell growth | |
| US4656131A (en) | Method for producing interferons | |
| EP0058687B1 (en) | Method of enhancing interferon production | |
| DE3784728T2 (de) | Reinigung von rekombinantem interleukin-1. | |
| CN1058022A (zh) | 制备干扰素α-2晶体的方法 | |
| Familletti et al. | Production of high levels of human leukocyte interferon from a continuous human myeloblast cell culture | |
| US4411992A (en) | Process for preparing murine interleukin 2 | |
| JPH04502014A (ja) | 結晶性ｒ―ｈ―ｇｍ―ｃｓｆ及びその製造方法 | |
| EP0094317A2 (en) | Production of interleukin and its analogous immune regulating factors | |
| CN1036794A (zh) | 一种增加细胞激动素产率的方法 | |
| DE69232259T2 (de) | Verfahren zur Herstellung von Interleukin-6 Zusammensetzungen | |
| US5468635A (en) | In vitro method for stimulating cell growth by culturing cells in a serum-free culture medium comprising human lysozyme | |
| US4452893A (en) | Cell growth medium supplement | |
| Yamamoto et al. | The human lung fibroblast cell line, MRC-5, produces multiple factors involved with megakaryocytopoiesis. | |
| Sakai et al. | Intraclonal diversity of fibrosarcoma cells for the production of macrophage colony‐stimulating factor and granulocyte colony‐stimulating factor | |
| Uittenbogaart et al. | Leukemia-derived growth factor (non-interleukin 2) produced by a human malignant T lymphoid cell line. | |
| CN113388579A (zh) | 一种含有细胞因子的可将造血干细胞分化为自然杀伤细胞的培养基及其分化方法 | |
| EP0597850B1 (en) | Crystalline interleukin-4 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination |